About TENMAC EM Tenofovir & Emtricitabine
TENMACEM
Each tablet contains
Tenofovir Disoproxil Fumarate 300 mg
Emtricitabine 200mg
CONTRAINDICATIONS
Do not use TENMACEM for preexposure prophylaxis in individuals with unknown or positive HIV1 status TENMACEM should be used in HIVinfected patients only in combination with other antiretroviral agents
SIDE EFFECTS
In HIV1 infected patients the most common adverse reactions incidence greater than or equal to 10 are diarrhea nausea fatigue headache dizziness depression insomnia abnormal dreams and rash In HIV1 uninfected individuals in PrEP trials adverse reactions that were reported by more than 2 of TENMACEM subjects and more frequently than by placebo subjects were headache abdominal pain and weight decreased
PACKING
HDPE Bottle packs of 30 tablets and packed in a unit carton along with package insert
SHELF LIFE AND STORAGE
24 months from the date of manufacturing below 30C
Effective HIV ManagementTENMAC EM is formulated with two proven antiretroviral agents-Tenofovir Disoproxil Fumarate and Emtricitabine. This combination inhibits the replication of HIV, helping suppress the viral load in patients. Continued, regular use as directed by a healthcare professional plays a vital role in managing HIV infection and improving the quality of life. The medicine is intended for use under strict supervision to ensure maximum benefit and safety.
Proper Storage for Maximum EfficacyTo sustain its medicinal properties, TENMAC EM must be stored at room temperature, ideally around 25C. A cool, dry environment away from moisture, heat, and direct sunlight is recommended. Ensuring optimal storage conditions preserves the tablets' effectiveness throughout their shelf life and prevents potential degradation.
FAQ's of TENMAC EM Tenofovir & Emtricitabine:
Q: How should TENMAC EM tablets be stored for optimal effectiveness?
A: TENMAC EM tablets should be stored at room temperature, around 25C, in a cool and dry place, away from direct sunlight and moisture. Proper storage ensures the medicine remains effective throughout its intended shelf life.
Q: What is the recommended usage of TENMAC EM for HIV-positive patients?
A: TENMAC EM is intended for HIV-positive patients and should only be taken as prescribed by a qualified physician. Never self-medicate or modify the dosage without medical advice.
Q: When should I take TENMAC EM tablets during the day?
A: It is important to follow the specific timing and dosage instructions provided by your physician. Usually, antiretroviral tablets like TENMAC EM are taken once daily, but always adhere to your healthcare provider's guidance.
Q: Where is TENMAC EM manufactured, and who supplies it?
A: TENMAC EM is manufactured in India, and is available through authorized distributors, exporters, importers, manufacturers, suppliers, and traders within the pharmaceutical sector.
Q: What is the process for procuring TENMAC EM if I am a distributor or supplier?
A: As a distributor or supplier, you can obtain TENMAC EM directly from licensed manufacturers or authorized agents in India. Ensure all procurement and distribution follow national and international regulatory guidelines.
Q: What benefits can patients expect from using TENMAC EM?
A: Patients using TENMAC EM as part of their HIV treatment regimen can expect a reduction in viral load, helping to slow disease progression and support immune system function, when taken consistently as directed by a physician.